Disproportionate right ventricular dysfunction and poor survival in group 3 pulmonary hypertension

Research output: Contribution to journalLetterpeer-review

24 Scopus citations
Original languageEnglish (US)
Pages (from-to)1496-1499
Number of pages4
JournalAmerican journal of respiratory and critical care medicine
Volume197
Issue number11
DOIs
StatePublished - Jun 1 2018

Bibliographical note

Funding Information:
K.W.P. is funded by NIH F32 HL129554. S.L.A. is supported by the Canada Foundation for Innovation (229252 and 33012), NIH RO1 HL113003, a Tier 1 Canada Research Chair in Mitochondrial Dynamics and Translational Medicine (950-229252), and a grant from the William J. Henderson Foundation. T.T. is funded by AHA Scientist Development Grant 15SDG25560048.

Funding Information:
K.W.P. is funded by NIH F32 HL129554. S.L.A. is supported by the Canada Foundation for Innovation (229252 and 33012), NIH RO1 HL113003, a Tier 1 Canada Research Chair in Mitochondrial Dynamics and Translational Medicine (950-229252), and a grant from the William J. Henderson Foundation. T.T. is funded by AHA Scientist Development Grant 15SDG25560048. Author Contributions: K.W.P. and T.T. conceived the study. K.W.P., L.R., F.K., and T.T. collected and analyzed the data. J.R.M. analyzed the data. K.W.P., S.L.A., M.P., E.K.W., and T.T. interpreted the results and wrote the manuscript.

Cite this